Fischer Imaging and R2 Technology to Develop Breast Cancer Technology
DENVER, Sept. 19 -- Fischer Imaging Corp. and R2 Technology Inc. announced they have signed a development and marketing agreement to customize CAD technology for use with Fischer's SenoScan Full Field Digital Mammography system. R2's CAD technology is designed to assist radiologists in detection of breast cancer. Under the agreement, Fischer Imaging will have sole worldwide distribution rights to its SenoScan Full Field Digital Mammography System integrated with R2's CAD technology. The combination of the two devices will require FDA approval for clinical use in the US, and the companies are...Read full article
Related content from Photonics Media
Published: September 2002